The Science of Fibroblasts
HOUSTON, September 14, 2023/PRNewswire/ – FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and
HOUSTON, September 12, 2023 /PRNewswire/ – FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts
Clinical-Stage Company Focused on Advancing Fibroblast Cell-Based Therapies for Treatment of Chronic Diseases HOUSTON, June 1, 2023/PRNewswire/ – FibroBiologics, a clinical-stage company focused on the
June 14, 2023
May 2, 2023
April 25, 2023
February 1, 2023
January 27, 2023
Founders Keepers Podcast
January 13, 2023
September 22, 2022
NPR TechNation
July 14, 2022
Finding Genius Podcast
June 20, 2022
Business of Biotech
June 6, 2022
Multiple Sclerosis News Today
May 25, 2022
Houston Innovators Podcast
April 7, 2022
Houston Business Journal
February 22, 2022
Empowered Patient Podcast
February 20, 2022
Health Professional Radio
February 10, 2022
Neurology Live
February 9, 2022
Neurology Live
